Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Karin Ashkenazi"'
Autor:
Yaron Goren, Xinmin Zhang, Marino E. Leon, Melissa Noller, Marian Hajduch, Kenneth A Berlin, Hila Benjamin, Mats Sanden, Yulia Strenov, Michal Kushnir, Hagai Marmor, Danit Lebanony, Sergey Vorobyov, Gila Lithwick-Yanai, Heather Mitchell, Eti Meiri, Syed Z. Ali, Nir Dromi, Vladimir Kravtsov, Olivia Dattner, Alexander Shtabsky, Leonor Leider-Trejo, Sara Morgenstern, Temima Schnitzer-Perlman, Karin Ashkenazi, Etti Kadosh, Alexis Smith, Dganit Bar, Sarit Tabak, Sharon Kredo-Russo, Christopher J. VandenBussche, Asia Zubkov, Meora Feinmesser, Maria Motin
Publikováno v:
Journal of Clinical Pathology
Aims The distinction between benign and malignant thyroid nodules has important therapeutic implications. Our objective was to develop an assay that could classify indeterminate thyroid nodules as benign or suspicious, using routinely prepared fine n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0448c5e3c26922d0d6a695aa8f13ee34
https://doi.org/10.1136/jclinpath-2016-204089
https://doi.org/10.1136/jclinpath-2016-204089
Autor:
Elizabeth Klinke, Wolf Mueller, Franz Fogt, Mats Sanden, Tina Bocker Edmonston, Yael Spector, Monica Huszar, Eti Meiri, Ulrike Lass, Karin Ashkenazi, Meora Feinmesser, Ilanit Burnstein, Shai Rosenwald, Iris Barshack, Nir Dromi, Eran Goren, Ranit Aharonov, Ayelet Chajut, Margot Werner, Merav Zepeniuk, Orit Zion
Publikováno v:
The Oncologist. 17:801-812
Background. Cancers of unknown primary origin (CUP) constitute 3%–5% (50,000 to 70,000 cases) of all newly diagnosed cancers per year in the United States. Including cancers of uncertain primary origin, the total number increases to 12%–15% (180,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a29fb88930895688cc8aca2630112b
https://doi.org/10.1634/theoncologist.2011-0466
https://doi.org/10.1634/theoncologist.2011-0466
A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma
Autor:
Zvi Bentwich, Hila Benjamin, Marina Perelman, Karin Ashkenazi, Naama Barabash, Iris Barshack, Ayelet Chajut, Nitzan Rosenfeld, Sara Morgenstern, Dalia Cohen, Lahav Cohen, Yaron Goren, Tina Bocker Edmonston, Hadas Gibori, Eran Goren, Ranit Aharonov, Shai Rosenwald, Danit Lebanony, Eti Meiri
Publikováno v:
The Journal of Molecular Diagnostics. 12:771-779
The definitive identification of malignant pleural mesothelioma (MPM) has significant clinical implications, yet other malignancies often involve the lung pleura, confounding the diagnosis of MPM. In the absence of accurate markers, MPM can be diffic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10de88b312d02303308fd1f47d8d874c
https://doi.org/10.2353/jmoldx.2010.090169
https://doi.org/10.2353/jmoldx.2010.090169
Autor:
Ronen Tamir, Ayelet Chajut, Hila Benjamin, Dvora Nass, Shlomit Gilad, Karin Ashkenazi, Danit Lebanony, Nitzan Rosenfeld, Yael Spector, Ilit Leizerman, Meital Ezagouri, Iris Barshack, Sima Benjamin, Meora Feinmesser, Shai Rosenwald, Nir Dromi, Eran Goren, Ranit Aharonov, Alexander Faerman, Ana Tobar
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(6)
Identification of the tissue of origin of a tumor is vital to its management. Previous studies showed tissue-specific expression patterns of microRNA and suggested that microRNA profiling would be useful in addressing this diagnostic challenge. Micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4882b4164ee8661d0e66b542a9c781
https://pubmed.ncbi.nlm.nih.gov/20348879
https://pubmed.ncbi.nlm.nih.gov/20348879
Autor:
Shlomit Gilad, Dalia Cohen, Avital Dov, Nir Gefen, Shai Izraeli, Mahesh Mansukhani, Meital Ezagouri, Danit Lebanony, Ayelet Chajut, Harvey I. Pass, Yael Spector, Nitzan Rosenfeld, Karin Ashkenazi, Gideon Rechavi, Hila Benjamin, Junjie Li, Ranit Aharonov, Daisuke Nonaka
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(12)
Purpose Recent advances in treatment of lung cancer require greater accuracy in the subclassification of non–small-cell lung cancer (NSCLC). Targeted therapies which inhibit tumor angiogenesis pose higher risk for adverse response in cases of squam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431b0e40a338e0deb5d8c9a830402e6b
https://pubmed.ncbi.nlm.nih.gov/19720885
https://pubmed.ncbi.nlm.nih.gov/19720885
Publikováno v:
Journal of Clinical Oncology. 31:e22173-e22173
e22173 Background: Molecular profiling of CUP may effectively identify the underlying tumor type and potentially influence treatment decisions and outcomes. A microRNA (miR) array has been shown in concordance studies at leading academic centers to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5727722d6633d2191144521a1855dbf1
https://doi.org/10.1200/jco.2013.31.15_suppl.e22173
https://doi.org/10.1200/jco.2013.31.15_suppl.e22173
Autor:
Robert Wassman, George Fountzilas, Anna Goussia, Karin Ashkenazi, Nicholas Palidis, Danit Lebanony, Eti Meiri, Katerina Stoyianni, George Pentheroudakis, Mats Sanden, Vassiliki Malamou-Mitsi
Publikováno v:
Cancer Research. 73:816-816
Background: Cancers of unknown primary origin (CUP) constitute 3%-5% (50,000 to 70,000 cases) of all newly diagnosed cancers per year in the United States. Including cancers of uncertain primary origin, the total number increases to 12%-15% (180,000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61afbeae6fd23488d7c9b3063c97ad10
https://doi.org/10.1158/1538-7445.am2013-816
https://doi.org/10.1158/1538-7445.am2013-816
Autor:
George Pentheroudakis, Vassiliki Malamou-Mitsi, Hila Benjamin, George Fountzilas, Dimitrios Krikelis, Brianna St. Cyr, Yael Spector, Anna Gousia, Mats Sanden, Eti Meiri, Aikaterini Stoyianni, Karin Ashkenazi, Vassiliki Kotoula, Nicholas Pavlidis
Publikováno v:
Journal of Clinical Oncology. 30:10575-10575
10575 Background: Identification of the tissue of origin of metastatic tumors is important for estimation of prognosis and patient management. Carcinoma of unknown primary (CUP) is not uncommon in oncology, representing 3-5% of all newly found malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91afe617ff6cfc1db9fcc2be5d5d5817
https://doi.org/10.1200/jco.2012.30.15_suppl.10575
https://doi.org/10.1200/jco.2012.30.15_suppl.10575
Autor:
Iris Barshack, Meital Ezagouri, Laurie Horowitz, Meora Feinmesser, Yajue Huang, Craig Thurm, Ayelet Chajut, Tina Bocker Edmonston, Marluce Bibbo, Y. Goren, Shlomit Gilad, Michal Kushnir, G. Lithwick Yanai, S. Benjamin, Hadas Gibori, C. Hogan, S. j. Hou, Karin Ashkenazi, Hila Benjamin
Publikováno v:
Journal of Clinical Oncology. 29:10531-10531
10528 Background: Lung cancer is the leading cause of cancer deaths in the US. Treatment options are determined by tumor subtyping, for which there is lack of standardized, objective, and highly accurate techniques. In 20%-30% of cases significant li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2faf484a70bb82b11469171cae1d083
https://doi.org/10.1200/jco.2011.29.15_suppl.10531
https://doi.org/10.1200/jco.2011.29.15_suppl.10531
Autor:
Yaron Niv, Marisa Halpern, Gideon Marshak, Ofer Purim, Nitzan Rosenfeld, Karin Ashkenazi, Michal Kushnir, Moshe Hoshen, Ronen Brenner, Miriam Ben David, Sara Morgenstern, Yulia Kundel, Baruch Brenner, Ayelet Chajut
Publikováno v:
World Journal of Gastroenterology. 17:3976
AIM: To compare the microRNA (miR) profiles in the primary tumor of patients with recurrent and non-recurrent gastric cancer. METHODS: The study group included 45 patients who underwent curative gastrectomies from 1995 to 2005 without adjuvant or neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6513087ade9bd86f1fa7d45eb85eb68
https://doi.org/10.3748/wjg.v17.i35.3976
https://doi.org/10.3748/wjg.v17.i35.3976